Skip to content
Clinical Trials – home
Research site

Studienzentrum Dr. Laßmann

Germany Obere Straße 18-20, 07318 Saalfeld, Germany

  • Conjunctivitis allergic · Rhinitis allergic · Asthma
  • Adults and children

About Specializations

Studienzentrum Dr. Laßmann in Saalfeld, Germany specialises in clinical trials of conditions such as Conjunctivitis allergic, Rhinitis allergic, Asthma, Seasonal allergy, and other specialisations. This site conducts important research.

Main research areas of the site

Allergy and Immunotherapy

The medical center is at the forefront of research in allergy and immunotherapy, focusing on innovative treatments for conditions such as allergic rhinitis and rhinoconjunctivitis induced by house dust mite allergies. The center's work in this area aims to improve the quality of life for patients suffering from moderate to severe allergic reactions.

  • Subcutaneous Immunotherapy (SCIT)
  • Allergic Rhinitis and Rhinoconjunctivitis
  • House Dust Mite Allergy

Through rigorous clinical trials, the center evaluates the efficacy of advanced immunotherapy treatments, contributing to the development of personalized medicine approaches in allergy management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Obere Straße 18-2007318 SaalfeldGermany
Recruiting now
no trials
Conditions studied
4

More sites in SaalfeldGermany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Allergy Therapeutics (UK) Limited
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Aluminium Hydroxide
  • Sponsor:HAL Allergy B.V.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Betula Pendula Pollen Allergoid, Mannan-Conjugated, Polymerised
  • Sponsor:CCDRD Cooperative Clinical Drug Research and Development AG
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Bilastine
  • Sponsor:Inmunotek S.L.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.